Hyaluronic Acid-FGF2-Derived Peptide Bioconjugates for Suppression of FGFR2 and AR Simultaneously as an Acne Antagonist

    February 2023 in “ Journal of nanobiotechnology
    Zijian Su, Hongjie Zhang, Jieqiong Cao, Yuanmeng Sun, Yuling Cai, Bihui Zhang, He Liu, Zilei Zhang, Jianwen Xie, Qilin Meng, Lin Luo, Fu Li, Jingsheng Li, Jin‐Ting Zhang, Xiaojia Chen, Hongyu An
    New to Hyaluronic Acid? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary In this study, HA-P5, a nanoparticle derived from peptide and polysaccharide conjugation, effectively reduced acne lesions and sebum production by inhibiting specific receptors in cells, without triggering unfavorable reactions compared to a commercial inhibitor, highlighting HA-P5's potential as a novel acne treatment.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study evaluates the effectiveness of HA-P5, a bioconjugate nanoparticle derived from hyaluronic acid and an FGF2 peptide, in treating acne by inhibiting FGFR2 and AR signaling pathways. HA-P5 significantly reduced acne lesions and sebum accumulation in SZ95 cells and rabbit models without inducing the overexpression of AKR1C3, unlike the commercial FGFR inhibitor AZD4547. The findings suggest that HA-P5 is a promising and safer alternative for acne treatment due to its dual inhibition mechanism and minimal side effects.
    Discuss this study in the Community →

    Research cited in this study

    12 / 12 results